Promising Therapeutic Strategies for Patients with Progressive Metastatic Non-Small Cell Lung Cancer
Dr Melissa Johnson from Sarah Cannon Research Institute in Nashville, Tennessee, discusses available data with antibody-drug conjugates with established and investigational targets in patients with non-small cell lung cancer, moderated by Dr Neil Love. Produced by Research To Practice. CME information and select publications here (https://www.researchtopractice.com/OncologyTodayCEACAM5NSCLC23).
